Lopid

Known as: Lipur, Lopid R 
 

Topic mentions per year

Topic mentions per year

1982-2016
02419822016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Functionalized magnetic carbonaceous nanomaterials, which are important materials with many practical and research applications… (More)
Is this relevant?
1999
1999
Renal and hepatic subacute toxicity induced by the antihyperlipidaemic drugs: Bezalip-Pravastatin and Lopid was investigated in… (More)
Is this relevant?
1995
1995
Hyperlipidemia is a common side-effect of oral retinoid treatment, which sometimes interferes with long-term therapy. To evaluate… (More)
Is this relevant?
1994
1994
Our specific aim was to assess severe hypertriglyceridemia and pancreatitis that occurred when postmenopausal estrogen… (More)
Is this relevant?
1993
1993
This randomized, parallel-group, multicenter clinical trial compared a newly developed, once-daily, extended-release formulation… (More)
Is this relevant?
1991
1991
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… (More)
Is this relevant?
1991
1991
Sensitive and specific methods for the simultaneous determination of gemfibrozil (Lopid), a lipid-lowering agent, and its… (More)
Is this relevant?
1989
1989
Thirteen patients with phenotypic type V hyperlipidemia were treated with either gemfibrozil (Lopid) or a placebo in a randomized… (More)
Is this relevant?
1985
1985
Gemfibrozil (Lopid) is a new plasma lipid-regulating drug that decreases very low and low density lipoprotein (VLD/LDL) and… (More)
Is this relevant?
1982
1982
This report describes the results of long-term treatment for blood lipid regulation with a new drug, gemfibrozil (Lopid). During… (More)
Is this relevant?